期刊文献+

RNA干扰在基因研究和治疗中的应用 被引量:1

下载PDF
导出
出处 《中国微循环》 北大核心 2007年第2期133-135,共3页 Journal of Chinese Microcirculation
  • 相关文献

参考文献18

  • 1Hannon GJ.RNA interference[J].Nature,2002,418(6894):244~251
  • 2Lipardi C,Wei Q,Paterson BM.RNAi as random degradative PCR.siRNA primers convent mRNA into dsRNA that are degraded to generate new siRNAs[J].Cell,2001,107(3):297~307
  • 3Dzitoyeva S,Dimitrijevic N,Manev H.Intra-abdominal injection of double-staranded RNA into anesthetized adult Drosophila triggers RNA interference in the central nervous system[J].Mol Psychiatry,2001,6(6):665
  • 4Sijen T,Fleenor J,et al.On the role of RNA amplification in dsRNA-triggered gene silencing[J].Cell,2002,107(4):465~467
  • 5Celotto AM,Graveley BR.Exon-specific RNAi:a tool for dissecting the functional relevance of alternative splicing[J].RNA,2002,8(6):718~724
  • 6Ashrafi K,Watts JL,Kamath RS,et al.Systematic functional analysis of the Caenorhabditis elegans enome using RNAi[J].Nature,2003,421(6920):231~237
  • 7Kamath RS,Ahringer J.Genome-wide RNAi screening in Caenorhabditis elegans[J].Methods,2003,30(4):313~321
  • 8Brummelkamp TR,Bernards R,Agami R.A system for stable expression of short interfering RNAs in mammalian cells[J].Science,2002,296(5567):550~553
  • 9Ditullio RA,Mochan TA,Venere M,et al.53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer[J].Nat Cell Biol,2002,4(12):998~999
  • 10Song E,Lee SK,Wang J,et al.RNA interference targeting Fas Protects mice form fulminant hepatitis[J].Nat Med,2003,9(3):347~351

同被引文献11

  • 1Zhou H, Kuang J, Zhong L, et al. Tumour amplified kinase STK 15/BTAK induees centrosome amplification, aneuploidy and transformation [ J ] .NatGenet, 1998,20(2): 189 - 193.
  • 2Miyoshi Y, Iwao K, Egawa C, et al. Association of centrosomal kinase STK 15/ BTAK mRNA expression with chromosomal instability in human breast cancers [ J ] . Int J Cancer, 2001, 92(3): 370 - 373.
  • 3Sen S, Zhou H, Zhang RD, et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer [ J ] . J Natl Cancer Inst, 2002,94 (17): 1320- 1329.
  • 4Kamada K, Yamada Y, Hirao T, et al. Amplification/overexpression of Aurom- A in human gastric carcinoma: potential role in differentiated type gastric carcinogenesis [ J ] . Oncol Rep, 2004, 12(3): 593 - 599.
  • 5Sun T, Miao X, Wang J, et al. Functional Phe31 IIe polymorphism in Aurora A and risk of breast carcinoma [ J ] . Carcinogenesis, 2004, 25(11): 2225 - 2230.
  • 6Chen SS, Chang PC, Cheng YW, et al. Suppression of the STK15 oncogenic activity requires a transactivation-iudependent p53 function [ J ] . EMBO J, 2002, 21(17): 4491 -4499.
  • 7Tong T, Zhong Y, Kong J, et al. Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma [ J ] . Clin Cancer Res, 2004, 10:7304 - 7310.
  • 8Ewart-Toland A, Dai Q, Gao YT, et al. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types [ J ] . Carcinogenesis, 2005, 26(8): 1368 -1373.
  • 9Marumoto T, Zhang D, Saya H. Aurora-A - a guardian of poles [ J ] . Nat Rev Cancer, 2005, 5(1): 42 - 50.
  • 10Milam MR, Gu J, Yang H, et al. STK15 F31I polymorphism is associated with increased uterine cancer risk: a pilot study [ J ] . Gynecol Oneol, 2007, 107 (1): 71 - 74.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部